RGS6
Basic information
Region (hg38): 14:71932429-72566530
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RGS6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 11 | ||||
missense | 29 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 4 | 1 | 7 | ||
non coding | 29 | 52 | 81 | |||
Total | 0 | 0 | 29 | 39 | 53 |
Variants in RGS6
This is a list of pathogenic ClinVar variants found in the RGS6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-71964493-C-T | Likely benign (Jul 21, 2018) | |||
14-71964738-C-T | Benign (Jun 06, 2019) | |||
14-71964747-A-G | Benign (Nov 06, 2019) | |||
14-71964838-C-T | not specified | Uncertain significance (Nov 18, 2023) | ||
14-71964864-G-A | not specified | Uncertain significance (Jun 27, 2022) | ||
14-71964882-C-T | Benign (Jan 05, 2024) | |||
14-72351907-G-T | Likely benign (Jul 03, 2019) | |||
14-72352071-CTTCTT-C | Likely benign (Aug 30, 2023) | |||
14-72352103-C-T | Benign/Likely benign (Oct 11, 2023) | |||
14-72352104-A-C | not specified | Uncertain significance (Jan 06, 2023) | ||
14-72352128-A-G | not specified | Uncertain significance (Jan 11, 2023) | ||
14-72352144-C-T | not specified | Uncertain significance (Nov 01, 2022) | ||
14-72352157-C-G | Likely benign (Aug 28, 2018) | |||
14-72352182-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
14-72352183-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
14-72352201-C-T | Benign/Likely benign (Jan 15, 2024) | |||
14-72352260-C-T | Likely benign (Feb 24, 2020) | |||
14-72454521-G-A | Likely benign (Mar 27, 2023) | |||
14-72454567-T-C | not specified | Uncertain significance (Mar 28, 2023) | ||
14-72454584-T-C | Uncertain significance (Aug 21, 2023) | |||
14-72454709-C-G | Benign (Jul 21, 2018) | |||
14-72457981-A-G | Likely benign (Nov 15, 2018) | |||
14-72458007-C-T | Likely benign (Apr 24, 2019) | |||
14-72458057-T-C | Likely benign (Apr 24, 2019) | |||
14-72458284-C-T | Likely benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RGS6 | protein_coding | protein_coding | ENST00000553525 | 17 | 631499 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.442 | 0.558 | 125721 | 0 | 26 | 125747 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.70 | 198 | 278 | 0.713 | 0.0000153 | 3259 |
Missense in Polyphen | 37 | 71.228 | 0.51946 | 859 | ||
Synonymous | 0.809 | 89 | 99.2 | 0.897 | 0.00000586 | 854 |
Loss of Function | 4.34 | 8 | 36.2 | 0.221 | 0.00000197 | 391 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000209 | 0.000209 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.0000548 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000132 | 0.000132 |
Middle Eastern | 0.0000548 | 0.0000544 |
South Asian | 0.0000660 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates G protein-coupled receptor signaling cascades. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form. The RGS6/GNB5 dimer enhances GNAO1 GTPase activity (PubMed:10521509). {ECO:0000269|PubMed:10521509}.;
- Pathway
- Myometrial Relaxation and Contraction Pathways;Calcium Regulation in the Cardiac Cell;Signaling by GPCR;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Signal Transduction;Metabolism of proteins;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Chaperonin-mediated protein folding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;Protein folding;G alpha (i) signalling events;GPCR signaling-G alpha i;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.0980
Intolerance Scores
- loftool
- 0.605
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.62
Haploinsufficiency Scores
- pHI
- 0.448
- hipred
- Y
- hipred_score
- 0.663
- ghis
- 0.634
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.555
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rgs6
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;regulation of G protein-coupled receptor signaling pathway;negative regulation of signal transduction;intracellular signal transduction;positive regulation of GTPase activity
- Cellular component
- nucleus;cytosol;plasma membrane;extrinsic component of membrane
- Molecular function
- GTPase activator activity;protein binding